These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

234 related articles for article (PubMed ID: 30456208)

  • 1. A glance at imaging bladder cancer.
    Salmanoglu E; Halpern E; Trabulsi EJ; Kim S; Thakur ML
    Clin Transl Imaging; 2018 Aug; 6(4):257-269. PubMed ID: 30456208
    [TBL] [Abstract][Full Text] [Related]  

  • 2. More advantages in detecting bone and soft tissue metastases from prostate cancer using
    Pianou NK; Stavrou PZ; Vlontzou E; Rondogianni P; Exarhos DN; Datseris IE
    Hell J Nucl Med; 2019; 22(1):6-9. PubMed ID: 30843003
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Imaging of Bladder Cancer: Standard Applications and Future Trends.
    Abouelkheir RT; Abdelhamid A; Abou El-Ghar M; El-Diasty T
    Medicina (Kaunas); 2021 Mar; 57(3):. PubMed ID: 33804350
    [TBL] [Abstract][Full Text] [Related]  

  • 4. PET/CT and MRI in Bladder Cancer.
    Bouchelouche K; Turkbey B; Choyke PL
    J Cancer Sci Ther; 2012 Jul; S14(1):. PubMed ID: 23471167
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Utilization of imaging for staging in bladder cancer: is there a role for MRI or PET-computed tomography?
    Cipollari S; Carnicelli G; Bicchetti M; Campa R; Pecoraro M; Panebianco V
    Curr Opin Urol; 2020 May; 30(3):377-386. PubMed ID: 32168196
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Pilot Study of [
    Eulitt PJ; Altun E; Sheikh A; Wong TZ; Woods ME; Rose TL; Wallen EM; Pruthi RS; Smith AB; Nielsen ME; Whang YE; Kim WY; Godley PA; Basch EM; David GU; Ramirez J; Deal AM; Rathmell WK; Chen RC; Bjurlin MA; Lin W; Lee JK; Milowsky MI
    Clin Genitourin Cancer; 2020 Oct; 18(5):378-386.e1. PubMed ID: 32147364
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Evaluating the impact of 18F-FDG-PET-CT on risk stratification and treatment adaptation for patients with muscle-invasive bladder cancer (EFFORT-MIBC): a phase II prospective trial.
    Verghote F; Poppe L; Verbeke S; Dirix P; Albersen M; De Meerleer G; Berghen C; Ost P; Villeirs G; De Visschere P; De Man K; De Maeseneer D; Rottey S; Van Praet C; Decaestecker K; Fonteyne V
    BMC Cancer; 2021 Oct; 21(1):1113. PubMed ID: 34663254
    [TBL] [Abstract][Full Text] [Related]  

  • 8. 11C-choline PET/CT and bladder cancer: lymph node metastasis assessment with pathological specimens as reference standard.
    Ceci F; Bianchi L; Graziani T; Castellucci P; Pultrone C; Eugenio B; Martorana G; Colletti PM; Rubello D; Fanti S; Schiavina R
    Clin Nucl Med; 2015 Feb; 40(2):e124-8. PubMed ID: 25247272
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Preoperative lymph-node staging of invasive urothelial bladder cancer with 18F-fluorodeoxyglucose positron emission tomography/computed axial tomography and magnetic resonance imaging: correlation with histopathology.
    Jensen TK; Holt P; Gerke O; Riehmann M; Svolgaard B; Marcussen N; Bouchelouche K
    Scand J Urol Nephrol; 2011 Mar; 45(2):122-8. PubMed ID: 21231796
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Role of PET/CT in muscle-invasive bladder cancer.
    Kim SK
    Transl Androl Urol; 2020 Dec; 9(6):2908-2919. PubMed ID: 33457264
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Lymph node imaging in bladder cancer.
    Salminen AP; Jambor I; Syvänen KT; Boström PJ
    Minerva Urol Nefrol; 2015 Dec; ():. PubMed ID: 26684180
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Update on novel imaging techniques for the detection of lymph node metastases in bladder cancer.
    Salminen AP; Jambor I; Syvanen KT; Bostrom PJ
    Minerva Urol Nefrol; 2016 Apr; 68(2):138-49. PubMed ID: 27271230
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Prospective Assessment of Vesical Imaging Reporting and Data System (VI-RADS) and Its Clinical Impact on the Management of High-risk Non-muscle-invasive Bladder Cancer Patients Candidate for Repeated Transurethral Resection.
    Del Giudice F; Barchetti G; De Berardinis E; Pecoraro M; Salvo V; Simone G; Sciarra A; Leonardo C; Gallucci M; Catalano C; Catto JWF; Panebianco V
    Eur Urol; 2020 Jan; 77(1):101-109. PubMed ID: 31699526
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Seeing is Believing: State of the Art Imaging of Bladder Cancer.
    Messina E; Pecoraro M; Pisciotti ML; Del Giudice F; Lucciola S; Bicchetti M; Laschena L; Roberto M; De Berardinis E; Franco G; Panebianco V
    Semin Radiat Oncol; 2023 Jan; 33(1):12-20. PubMed ID: 36517189
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Imaging bladder cancer.
    Cowan NC; Crew JP
    Curr Opin Urol; 2010 Sep; 20(5):409-13. PubMed ID: 20625298
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The role of ultrasound in primary workup of cervical cancer staging (ESGO, ESTRO, ESP cervical cancer guidelines).
    Fischerová D; Cibula D
    Ceska Gynekol; 2019; 84(1):40-48. PubMed ID: 31213057
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The role of positron emission tomography using carbon-11 and fluorine-18 choline in tumors other than prostate cancer: a systematic review.
    Treglia G; Giovannini E; Di Franco D; Calcagni ML; Rufini V; Picchio M; Giordano A
    Ann Nucl Med; 2012 Jul; 26(6):451-61. PubMed ID: 22566040
    [TBL] [Abstract][Full Text] [Related]  

  • 18. An evaluation of morphological and functional multi-parametric MRI sequences in classifying non-muscle and muscle invasive bladder cancer.
    Panebianco V; De Berardinis E; Barchetti G; Simone G; Leonardo C; Grompone MD; Del Monte M; Carano D; Gallucci M; Catto J; Catalano C
    Eur Radiol; 2017 Sep; 27(9):3759-3766. PubMed ID: 28181054
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Whole body magnetic resonance with diffusion weighted sequence with body signal suppression compared to (18)F-FDG PET/CT in newly diagnosed lymphoma.
    Ferrari C; Minoia C; Asabella AN; Nicoletti A; Altini C; Antonica F; Ficco M; Guarini A; Maggialetti N; Rubini G
    Hell J Nucl Med; 2014; 17 Suppl 1():40-9. PubMed ID: 24392468
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Diuretic 18F-FDG PET/CT imaging for detection and locoregional staging of urinary bladder cancer: prospective evaluation of a novel technique.
    Nayak B; Dogra PN; Naswa N; Kumar R
    Eur J Nucl Med Mol Imaging; 2013 Feb; 40(3):386-93. PubMed ID: 23179944
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.